Labiotech.eu

deCODE genetics whole genome sequencing uk biobank

News and Trends 13 Sep 2019

Icelandic Company to Sequence 225,000 Genomes from UK Patients

The Icelandic genomics company deCODE genetics has joined the UK’s Wellcome Sanger Institute in sequencing 450,000 genomes as part of a massive €224M (£200M) project organized by the UK Biobank initiative. The UK Biobank’s €224M grant includes €56M (£50M) from the UK government, €56M from the UK’s Wellcome Trust charity, and €112M (£100M) from big […]

September 13, 2019 - 3 minutesmins - By Jonathan Smith

Startup Scout 13 Sep 2019

This Biotech Makes Meat Substitutes from Crops Using Fungi

We’re traveling to Glasgow, UK, this week. The biotech 3F BIO is using fungi to convert plant sugars into proteins in a process that uses less than half of the water and feed that farming animal meat requires. Mission: To turn plant sugars into proteins using fungi, which could help to feed the growing world’s […]

September 13, 2019 - 4 minutesmins - By Jonathan Smith

Inside Labiotech 12 Sep 2019

Prost🍺! Labiotech is the Main Media Partner of the 25th Edition of BIO-Europe!

This is an extraordinary year for BIO-Europe, because it’s celebrating its 25th anniversary. Congratulations! 🎉 As Europe’s biggest biotech event, Bio-Europe attracted 4,300+ attendees from 2,300+ companies in 2018. What’s even more amazing is that they helped coordinate over 26,000 meetings where biotech professionals gathered around to partner with each other and foster innovation. Labiotech […]

September 12, 2019 - 3 minutesmins - By Yi-Jen Chang

More News! 12 Sep 2019

French Biotech to Develop Septic Shock Therapy with €39M Series B

The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside Ventures, the Series B round will finance a phase IIb trial of Inotrem’s lead candidate drug nangibotide, expected to start in November this year. […]

September 12, 2019 - 3 minutesmins - By Jonathan Smith

Expert Advice 12 Sep 2019

Interview: The Do’s & Don’ts of Branded Content in the Life Sciences Industry

Although it’s becoming increasingly popular in life science marketing, branded content is still in its infancy. This does not mean it isn’t worth investing in. Quite the contrary: because it is fairly new, it is all the more exciting and can reach promising audiences within the life sciences industry. While other industries have long since […]

September 12, 2019 - 12 minutesmins - By Larissa Warneck-Silvestrin

More News! 11 Sep 2019

Dutch Company Raises €60M to Treat Inherited Inflammatory Disease

The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […]

September 11, 2019 - 2 minutesmins - By Jonathan Smith

Switzerland Hôpitaux Universitaires Genève HUG

News and Trends 11 Sep 2019

IBM’s Watson for Genomics Launches in First European Hospital

The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […]

September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

grunenthal mesoblast chronic low back pain

News and Trends 11 Sep 2019

Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy

The German pharmaceutical company Grünenthal has licensed a donor cell therapy for chronic low back pain from the Australian biotech Mesoblast in a deal that could be worth over €900M. Under the terms of the deal, Grünenthal will gain exclusive rights to commercialize Mesoblast’s cell therapy for chronic low back pain in Europe and Latin […]

September 11, 2019 - 2 minutesmins - By Jonathan Smith

blood cancer stem cell therapy brain cancer

News and Trends 11 Sep 2019

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

The Italian biotech Genenta Science has raised €13.2M in a private round to fund two ongoing phase I/II trials of its stem cell therapy Temferon for blood and brain cancer. Genenta Science will use the money to fund two European phase I/II trials, which the company launched in March. One trial is testing the stem […]

September 11, 2019 - 3 minutesmins - By Jonathan Smith

oncimmune liquid biopsy lung cancer test

News and Trends 10 Sep 2019

Blood Test Increases Early Lung Cancer Diagnosis in UK Trial

A blood test for anti-cancer antibodies, developed by the UK diagnostics company Oncimmune, detected more early cases of lung cancer than standard clinical monitoring procedures in a trial with more than 12,000 patients. Oncimmune’s trial recruited 12,209 patients with a high risk of developing lung cancer through smoking and family history, and monitored them for […]

September 10, 2019 - 3 minutesmins - By Jonathan Smith

gene therapy cell therapy advanced therapy 4BIO

News and Trends 9 Sep 2019

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

The London-based life sciences investor 4BIO Capital has raised €45M in the first close of a fund to nurture companies developing advanced therapies such as gene and cell therapies. This is the first closing of 4BIO’s second fund, called 4BIO Ventures II, which is expected to total €136M ($150M) by late 2020. The fund will […]

September 9, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 9 Sep 2019

Top 10 Food Tech Companies in Europe in 2019

Food tech companies in Europe are striving to change how food is made to bring us closer to a more sustainable future. Here are some of the top companies you’ll find in this field. Food doesn’t just keep us alive, it is part of our culture and our daily routine, and it plays a key […]

September 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Icelandic Company to Sequence 225,000 Genomes from UK Patients

This Biotech Makes Meat Substitutes from Crops Using Fungi

Prost🍺! Labiotech is the Main Media Partner of the 25th Edition of BIO-Europe!

French Biotech to Develop Septic Shock Therapy with €39M Series B

Interview: The Do’s & Don’ts of Branded Content in the Life Sciences Industry

Dutch Company Raises €60M to Treat Inherited Inflammatory Disease

IBM’s Watson for Genomics Launches in First European Hospital

Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

Blood Test Increases Early Lung Cancer Diagnosis in UK Trial

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

Top 10 Food Tech Companies in Europe in 2019

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!